|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CEL-CPA1 (FusionGDB2 ID:15577) |
Fusion Gene Summary for CEL-CPA1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CEL-CPA1 | Fusion gene ID: 15577 | Hgene | Tgene | Gene symbol | CEL | CPA1 | Gene ID | 1056 | 1357 |
| Gene name | carboxyl ester lipase | carboxypeptidase A1 | |
| Synonyms | BAL|BSDL|BSSL|CELL|CEase|FAP|FAPP|LIPA|MODY8 | CPA | |
| Cytomap | 9q34.13 | 7q32.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | bile salt-activated lipasebile salt-dependent lipase, oncofetal isoformbucelipasecarboxyl ester hydrolasecarboxyl ester lipase (bile salt-stimulated lipase)cholesterol esterasefetoacinar pancreatic proteinlysophospholipase, pancreaticsterol estera | carboxypeptidase A1carboxypeptidase A1 (pancreatic)pancreatic carboxypeptidase A | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P19835 | P15085 | |
| Ensembl transtripts involved in fusion gene | ENST00000351304, ENST00000372080, | ENST00000011292, ENST00000484324, | |
| Fusion gene scores | * DoF score | 4 X 7 X 3=84 | 6 X 8 X 2=96 |
| # samples | 8 | 7 | |
| ** MAII score | log2(8/84*10)=-0.070389327891398 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/96*10)=-0.45567948377619 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CEL [Title/Abstract] AND CPA1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CEL(135937455)-CPA1(130027665), # samples:1 CEL(135940149)-CPA1(130024987), # samples:1 CEL(135959906)-CPA1(130027861), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | CEL-CPA1 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. CEL-CPA1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. CEL-CPA1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CEL | GO:0006707 | cholesterol catabolic process | 12031288 |
| Hgene | CEL | GO:0030157 | pancreatic juice secretion | 1854805 |
| Fusion gene breakpoints across CEL (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CPA1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | PAAD | TCGA-F2-6880-01A | CEL | chr9 | 135937455 | + | CPA1 | chr7 | 130027665 | + |
| ChimerDB4 | PAAD | TCGA-IB-7652-01A | CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024987 | + |
| ChimerDB4 | PAAD | TCGA-IB-AAUM | CEL | chr9 | 135959906 | + | CPA1 | chr7 | 130027861 | + |
Top |
Fusion Gene ORF analysis for CEL-CPA1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000351304 | ENST00000011292 | CEL | chr9 | 135937455 | + | CPA1 | chr7 | 130027665 | + |
| Frame-shift | ENST00000351304 | ENST00000484324 | CEL | chr9 | 135937455 | + | CPA1 | chr7 | 130027665 | + |
| Frame-shift | ENST00000372080 | ENST00000011292 | CEL | chr9 | 135937455 | + | CPA1 | chr7 | 130027665 | + |
| Frame-shift | ENST00000372080 | ENST00000484324 | CEL | chr9 | 135937455 | + | CPA1 | chr7 | 130027665 | + |
| In-frame | ENST00000351304 | ENST00000011292 | CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024987 | + |
| In-frame | ENST00000351304 | ENST00000484324 | CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024987 | + |
| In-frame | ENST00000372080 | ENST00000011292 | CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024987 | + |
| In-frame | ENST00000372080 | ENST00000484324 | CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024987 | + |
| intron-3UTR | ENST00000351304 | ENST00000011292 | CEL | chr9 | 135959906 | + | CPA1 | chr7 | 130027861 | + |
| intron-3UTR | ENST00000351304 | ENST00000484324 | CEL | chr9 | 135959906 | + | CPA1 | chr7 | 130027861 | + |
| intron-3UTR | ENST00000372080 | ENST00000011292 | CEL | chr9 | 135959906 | + | CPA1 | chr7 | 130027861 | + |
| intron-3UTR | ENST00000372080 | ENST00000484324 | CEL | chr9 | 135959906 | + | CPA1 | chr7 | 130027861 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000351304 | CEL | chr9 | 135940149 | + | ENST00000011292 | CPA1 | chr7 | 130024987 | + | 915 | 365 | 13 | 837 | 274 |
| ENST00000351304 | CEL | chr9 | 135940149 | + | ENST00000484324 | CPA1 | chr7 | 130024987 | + | 941 | 365 | 918 | 1 | 306 |
| ENST00000372080 | CEL | chr9 | 135940149 | + | ENST00000011292 | CPA1 | chr7 | 130024987 | + | 915 | 365 | 13 | 837 | 274 |
| ENST00000372080 | CEL | chr9 | 135940149 | + | ENST00000484324 | CPA1 | chr7 | 130024987 | + | 941 | 365 | 918 | 1 | 306 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000351304 | ENST00000011292 | CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024987 | + | 0.014234873 | 0.98576516 |
| ENST00000351304 | ENST00000484324 | CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024987 | + | 0.012589223 | 0.98741084 |
| ENST00000372080 | ENST00000011292 | CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024987 | + | 0.014234873 | 0.98576516 |
| ENST00000372080 | ENST00000484324 | CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024987 | + | 0.012589223 | 0.98741084 |
Top |
Fusion Genomic Features for CEL-CPA1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024986 | + | 0.11096225 | 0.8890377 |
| CEL | chr9 | 135937455 | + | CPA1 | chr7 | 130027664 | + | 1.74E-06 | 0.9999982 |
| CEL | chr9 | 135940149 | + | CPA1 | chr7 | 130024986 | + | 0.11096225 | 0.8890377 |
| CEL | chr9 | 135937455 | + | CPA1 | chr7 | 130027664 | + | 1.74E-06 | 0.9999982 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for CEL-CPA1 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:135937455/chr7:130027665) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CEL | CPA1 |
| FUNCTION: Catalyzes the hydrolysis of a wide range of substrates including cholesteryl esters, phospholipids, lysophospholipids, di- and tri-acylglycerols, and fatty acid esters of hydroxy fatty acids (FAHFAs) (PubMed:8471055, PubMed:27509211, PubMed:10220579, PubMed:27650499). Preferentially hydrolyzes FAHFAs with the ester bond further away from the carboxylate. Unsaturated FAHFAs are hydrolyzed more quickly than saturated FAHFAs (By similarity). Has an essential role in the complete digestion of dietary lipids and their intestinal absorption, along with the absorption of fat-soluble vitamins (PubMed:8471055, PubMed:27509211, PubMed:10220579, PubMed:27650499). {ECO:0000250|UniProtKB:Q64285, ECO:0000269|PubMed:10220579, ECO:0000269|PubMed:27509211, ECO:0000269|PubMed:27650499, ECO:0000269|PubMed:8471055}. | FUNCTION: Carboxypeptidase that catalyzes the release of a C-terminal amino acid, but has little or no action with -Asp, -Glu, -Arg, -Lys or -Pro (PubMed:8806703). Catalyzes the conversion of leukotriene C4 to leukotriene F4 via the hydrolysis of an amide bond (By similarity). {ECO:0000250|UniProtKB:P00730, ECO:0000269|PubMed:8806703}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | CPA1 | chr9:135940149 | chr7:130024987 | ENST00000011292 | 6 | 10 | 307_308 | 262 | 420.0 | Region | Substrate binding |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 21_121 | 113 | 688.0 | Region | Note=Heparin-binding |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 559_745 | 113 | 688.0 | Region | Note=17 X 11 AA tandem repeats%2C glycodomain%2C O-linked (mucin type) |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 559_569 | 113 | 688.0 | Repeat | Note=1 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 570_580 | 113 | 688.0 | Repeat | Note=2 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 581_591 | 113 | 688.0 | Repeat | Note=3 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 592_602 | 113 | 688.0 | Repeat | Note=4 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 603_613 | 113 | 688.0 | Repeat | Note=5 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 614_624 | 113 | 688.0 | Repeat | Note=6 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 625_635 | 113 | 688.0 | Repeat | Note=7 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 636_646 | 113 | 688.0 | Repeat | Note=8 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 647_657 | 113 | 688.0 | Repeat | Note=9 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 658_668 | 113 | 688.0 | Repeat | Note=10 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 669_679 | 113 | 688.0 | Repeat | Note=11 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 680_690 | 113 | 688.0 | Repeat | Note=12 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 691_701 | 113 | 688.0 | Repeat | Note=13 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 702_712 | 113 | 688.0 | Repeat | Note=14 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 713_723 | 113 | 688.0 | Repeat | Note=15 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 724_734 | 113 | 688.0 | Repeat | Note=16 |
| Hgene | CEL | chr9:135940149 | chr7:130024987 | ENST00000351304 | + | 3 | 10 | 735_745 | 113 | 688.0 | Repeat | Note=17 |
| Tgene | CPA1 | chr9:135940149 | chr7:130024987 | ENST00000011292 | 6 | 10 | 179_182 | 262 | 420.0 | Region | Substrate binding | |
| Tgene | CPA1 | chr9:135940149 | chr7:130024987 | ENST00000011292 | 6 | 10 | 254_255 | 262 | 420.0 | Region | Substrate binding |
Top |
Fusion Gene Sequence for CEL-CPA1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >15577_15577_1_CEL-CPA1_CEL_chr9_135940149_ENST00000351304_CPA1_chr7_130024987_ENST00000011292_length(transcript)=915nt_BP=365nt GGCCACCCAGAGGCTGATGCTCACCATGGGGCGCCTGCAACTGGTTGTGTTGGGCCTCACCTGCTGCTGGGCAGTGGCGAGTGCCGCGAA GCTGGGCGCCGTGTACACAGAAGGTGGGTTCGTGGAAGGCGTCAATAAGAAGCTCGGCCTCCTGGGTGACTCTGTGGACATCTTCAAGGG CATCCCCTTCGCAGCTCCCACCAAGGCCCTGGAAAATCCTCAGCCACATCCTGGCTGGCAAGGGACCCTGAAGGCCAAGAACTTCAAGAA GAGATGCCTGCAGGCCACCATCACCCAGGACAGCACCTACGGGGATGAAGACTGCCTGTACCTCAACATTTGGGTGCCCCAGGGCAGGAA GCAAGTGTCCGGAGCCAGCAGTAACCCCTGCTCGGAGACTTACCACGGCAAGTTTGCCAATTCCGAAGTGGAGGTCAAGTCCATTGTAGA CTTTGTGAAGGACCATGGGAACATCAAGGCCTTCATCTCCATCCACAGCTACTCCCAGCTCCTCATGTATCCCTATGGCTACAAAACAGA ACCAGTCCCTGACCAGGATGAGCTGGATCAGCTTTCCAAGGCTGCTGTGACAGCCCTGGCCTCTCTCTACGGGACCAAGTTCAACTATGG CAGCATCATCAAGGCAATTTATCAAGCCAGTGGAAGCACTATTGACTGGACCTACAGCCAGGGCATCAAGTACTCCTTCACCTTCGAGCT CCGGGACACTGGGCGCTATGGCTTCCTGCTGCCAGCCTCCCAGATCATCCCCACAGCCAAGGAGACGTGGCTGGCGCTTCTGACCATCAT GGAGCACACCCTGAATCACCCCTACTGAGCTGACCCTTTGACACCCTTCTTGTCCTCCTCTCTGGCCCCATCCAGGCAACCAAATAAAGT >15577_15577_1_CEL-CPA1_CEL_chr9_135940149_ENST00000351304_CPA1_chr7_130024987_ENST00000011292_length(amino acids)=274AA_BP=117 MMLTMGRLQLVVLGLTCCWAVASAAKLGAVYTEGGFVEGVNKKLGLLGDSVDIFKGIPFAAPTKALENPQPHPGWQGTLKAKNFKKRCLQ ATITQDSTYGDEDCLYLNIWVPQGRKQVSGASSNPCSETYHGKFANSEVEVKSIVDFVKDHGNIKAFISIHSYSQLLMYPYGYKTEPVPD QDELDQLSKAAVTALASLYGTKFNYGSIIKAIYQASGSTIDWTYSQGIKYSFTFELRDTGRYGFLLPASQIIPTAKETWLALLTIMEHTL -------------------------------------------------------------- >15577_15577_2_CEL-CPA1_CEL_chr9_135940149_ENST00000351304_CPA1_chr7_130024987_ENST00000484324_length(transcript)=941nt_BP=365nt GGCCACCCAGAGGCTGATGCTCACCATGGGGCGCCTGCAACTGGTTGTGTTGGGCCTCACCTGCTGCTGGGCAGTGGCGAGTGCCGCGAA GCTGGGCGCCGTGTACACAGAAGGTGGGTTCGTGGAAGGCGTCAATAAGAAGCTCGGCCTCCTGGGTGACTCTGTGGACATCTTCAAGGG CATCCCCTTCGCAGCTCCCACCAAGGCCCTGGAAAATCCTCAGCCACATCCTGGCTGGCAAGGGACCCTGAAGGCCAAGAACTTCAAGAA GAGATGCCTGCAGGCCACCATCACCCAGGACAGCACCTACGGGGATGAAGACTGCCTGTACCTCAACATTTGGGTGCCCCAGGGCAGGAA GCAAGTGTCCGGAGCCAGCAGTAACCCCTGCTCGGAGACTTACCACGGCAAGTTTGCCAATTCCGAAGTGGAGGTCAAGTCCATTGTAGA CTTTGTGAAGGACCATGGGAACATCAAGGCCTTCATCTCCATCCACAGCTACTCCCAGCTCCTCATGTATCCCTATGGCTACAAAACAGA ACCAGTCCCTGACCAGGATGAGCTGGATCAGCTTTCCAAGGCTGCTGTGACAGCCCTGGCCTCTCTCTACGGGACCAAGTTCAACTATGG CAGCATCATCAAGGCAATTTATCAAGCCAGTGGAAGCACTATTGACTGGACCTACAGCCAGGGCATCAAGTACTCCTTCACCTTCGAGCT CCGGGACACTGGGCGCTATGGCTTCCTGCTGCCAGCCTCCCAGATCATCCCCACAGCCAAGGAGACGTGGCTGGCGCTTCTGACCATCAT GGAGCACACCCTGAATCACCCCTACTGAGCTGACCCTTTGACACCCTTCTTGTCCTCCTCTCTGGCCCCATCCAGGCAACCAAATAAAGT >15577_15577_2_CEL-CPA1_CEL_chr9_135940149_ENST00000351304_CPA1_chr7_130024987_ENST00000484324_length(amino acids)=306AA_BP=1 MFLVHSNFIWLPGWGQRGGQEGCQRVSSVGVIQGVLHDGQKRQPRLLGCGDDLGGWQQEAIAPSVPELEGEGVLDALAVGPVNSASTGLI NCLDDAAIVELGPVERGQGCHSSLGKLIQLILVRDWFCFVAIGIHEELGVAVDGDEGLDVPMVLHKVYNGLDLHFGIGKLAVVSLRAGVT AGSGHLLPALGHPNVEVQAVFIPVGAVLGDGGLQASLLEVLGLQGPLPARMWLRIFQGLGGSCEGDALEDVHRVTQEAELLIDAFHEPTF -------------------------------------------------------------- >15577_15577_3_CEL-CPA1_CEL_chr9_135940149_ENST00000372080_CPA1_chr7_130024987_ENST00000011292_length(transcript)=915nt_BP=365nt GGCCACCCAGAGGCTGATGCTCACCATGGGGCGCCTGCAACTGGTTGTGTTGGGCCTCACCTGCTGCTGGGCAGTGGCGAGTGCCGCGAA GCTGGGCGCCGTGTACACAGAAGGTGGGTTCGTGGAAGGCGTCAATAAGAAGCTCGGCCTCCTGGGTGACTCTGTGGACATCTTCAAGGG CATCCCCTTCGCAGCTCCCACCAAGGCCCTGGAAAATCCTCAGCCACATCCTGGCTGGCAAGGGACCCTGAAGGCCAAGAACTTCAAGAA GAGATGCCTGCAGGCCACCATCACCCAGGACAGCACCTACGGGGATGAAGACTGCCTGTACCTCAACATTTGGGTGCCCCAGGGCAGGAA GCAAGTGTCCGGAGCCAGCAGTAACCCCTGCTCGGAGACTTACCACGGCAAGTTTGCCAATTCCGAAGTGGAGGTCAAGTCCATTGTAGA CTTTGTGAAGGACCATGGGAACATCAAGGCCTTCATCTCCATCCACAGCTACTCCCAGCTCCTCATGTATCCCTATGGCTACAAAACAGA ACCAGTCCCTGACCAGGATGAGCTGGATCAGCTTTCCAAGGCTGCTGTGACAGCCCTGGCCTCTCTCTACGGGACCAAGTTCAACTATGG CAGCATCATCAAGGCAATTTATCAAGCCAGTGGAAGCACTATTGACTGGACCTACAGCCAGGGCATCAAGTACTCCTTCACCTTCGAGCT CCGGGACACTGGGCGCTATGGCTTCCTGCTGCCAGCCTCCCAGATCATCCCCACAGCCAAGGAGACGTGGCTGGCGCTTCTGACCATCAT GGAGCACACCCTGAATCACCCCTACTGAGCTGACCCTTTGACACCCTTCTTGTCCTCCTCTCTGGCCCCATCCAGGCAACCAAATAAAGT >15577_15577_3_CEL-CPA1_CEL_chr9_135940149_ENST00000372080_CPA1_chr7_130024987_ENST00000011292_length(amino acids)=274AA_BP=117 MMLTMGRLQLVVLGLTCCWAVASAAKLGAVYTEGGFVEGVNKKLGLLGDSVDIFKGIPFAAPTKALENPQPHPGWQGTLKAKNFKKRCLQ ATITQDSTYGDEDCLYLNIWVPQGRKQVSGASSNPCSETYHGKFANSEVEVKSIVDFVKDHGNIKAFISIHSYSQLLMYPYGYKTEPVPD QDELDQLSKAAVTALASLYGTKFNYGSIIKAIYQASGSTIDWTYSQGIKYSFTFELRDTGRYGFLLPASQIIPTAKETWLALLTIMEHTL -------------------------------------------------------------- >15577_15577_4_CEL-CPA1_CEL_chr9_135940149_ENST00000372080_CPA1_chr7_130024987_ENST00000484324_length(transcript)=941nt_BP=365nt GGCCACCCAGAGGCTGATGCTCACCATGGGGCGCCTGCAACTGGTTGTGTTGGGCCTCACCTGCTGCTGGGCAGTGGCGAGTGCCGCGAA GCTGGGCGCCGTGTACACAGAAGGTGGGTTCGTGGAAGGCGTCAATAAGAAGCTCGGCCTCCTGGGTGACTCTGTGGACATCTTCAAGGG CATCCCCTTCGCAGCTCCCACCAAGGCCCTGGAAAATCCTCAGCCACATCCTGGCTGGCAAGGGACCCTGAAGGCCAAGAACTTCAAGAA GAGATGCCTGCAGGCCACCATCACCCAGGACAGCACCTACGGGGATGAAGACTGCCTGTACCTCAACATTTGGGTGCCCCAGGGCAGGAA GCAAGTGTCCGGAGCCAGCAGTAACCCCTGCTCGGAGACTTACCACGGCAAGTTTGCCAATTCCGAAGTGGAGGTCAAGTCCATTGTAGA CTTTGTGAAGGACCATGGGAACATCAAGGCCTTCATCTCCATCCACAGCTACTCCCAGCTCCTCATGTATCCCTATGGCTACAAAACAGA ACCAGTCCCTGACCAGGATGAGCTGGATCAGCTTTCCAAGGCTGCTGTGACAGCCCTGGCCTCTCTCTACGGGACCAAGTTCAACTATGG CAGCATCATCAAGGCAATTTATCAAGCCAGTGGAAGCACTATTGACTGGACCTACAGCCAGGGCATCAAGTACTCCTTCACCTTCGAGCT CCGGGACACTGGGCGCTATGGCTTCCTGCTGCCAGCCTCCCAGATCATCCCCACAGCCAAGGAGACGTGGCTGGCGCTTCTGACCATCAT GGAGCACACCCTGAATCACCCCTACTGAGCTGACCCTTTGACACCCTTCTTGTCCTCCTCTCTGGCCCCATCCAGGCAACCAAATAAAGT >15577_15577_4_CEL-CPA1_CEL_chr9_135940149_ENST00000372080_CPA1_chr7_130024987_ENST00000484324_length(amino acids)=306AA_BP=1 MFLVHSNFIWLPGWGQRGGQEGCQRVSSVGVIQGVLHDGQKRQPRLLGCGDDLGGWQQEAIAPSVPELEGEGVLDALAVGPVNSASTGLI NCLDDAAIVELGPVERGQGCHSSLGKLIQLILVRDWFCFVAIGIHEELGVAVDGDEGLDVPMVLHKVYNGLDLHFGIGKLAVVSLRAGVT AGSGHLLPALGHPNVEVQAVFIPVGAVLGDGGLQASLLEVLGLQGPLPARMWLRIFQGLGGSCEGDALEDVHRVTQEAELLIDAFHEPTF -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CEL-CPA1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CEL-CPA1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CEL-CPA1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies